Quantitative structure activity relationship analysis of angiotensin II AT1 receptor antagonists

Medicinal Chemistry Research

Volumn 19, Issue 5, 2010, Pages 475-489

  Paliwal, Sarvesh Kumar ^a   Pal, Mahima ^a   Siddiqui, Anees A ^b  

^a BANASTHALI UNIVERSITY   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

AT1 receptor antagonists; MLR; PLS; QSAR; TSAR

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENZENE DERIVATIVE; HYDANTOIN DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG DETERMINATION; ENERGY; HYDROPHOBICITY; MULTIPLE LINEAR REGRESSION ANALYSIS; PARTIAL LEAST SQUARES REGRESSION; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL ANALYSIS;

EID: 77953324494     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-009-9205-9     Document Type: Article

References (18)

1. RD Cramer 1993 Partial Least Squares (PLS): its strengths and limitations Perspect Drug Discov Des 1 269 278 10.1007/BF02174528 10.1007/BF02174528 1:CAS:528:DyaK2cXis1Smsbo%3D
2. JJ Edmunds S Klutchko JM Hamby AM Bunker CJC Connolly 1995 Derivatives of [[1-4(4-carboxybenzyl)imidazolyl]methylidene]hydantoins as orally active angiotensin II receptor antagonists J Med Chem 38 3759 3771 10.1021/jm00019a005 10.1021/jm00019a005 1:CAS:528:DyaK2MXotFOrsrk%3D 7562906
3. DJ Fogarty MV Sanchez-Gomez C Matute 2002 Multiple angiotensin receptor subtypes in normal and tumor astrocytes in vitro Glia 39 304 313 10.1002/glia.10117 10.1002/glia.10117 12203396
4. D Henrion N Kubis BI Levy 2001 Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: from large arteries to the microcirculation Hypertension 38 1150 1157 10.1161/hy1101.096109 10.1161/hy1101.096109 1:CAS:528:DC%2BD3MXovVOrtro%3D 11711513
5. L Juillerat-Jeanneret J Celerier C ChapuisBernasconi G Nguyen W Wostl HP Maerki RC Janzer P Corvol JM Gasc 2004 Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma Br J Cancer 90 1059 1068 10.1038/sj.bjc.6601646 10.1038/sj.bjc.6601646 1:CAS:528:DC%2BD2cXhslWrsbo%3D 14997208 (Pubitemid 38495829)
6. KH Kim 2007 Outliers in SAR and QSAR: 2. Is a flexible binding site a possible source of outliers? J Comput Aided Mol Des 21 421 435 10.1007/s10822-007-9126-y 10.1007/s10822-007-9126-y 1:CAS:528:DC%2BD2sXhtVagurzE 17646926 (Pubitemid 47423276)
7. JB Kostis B Shelton G Gossein 1996 Adverse effects of enalapril in the studies of left ventricular dysfunction Am Heart J 131 350 355 10.1016/S0002-8703(96)90365-8 10.1016/S0002-8703(96)90365-8 1:CAS:528: DyaK28Xhs1Sgs7w%3D 8579032 (Pubitemid 26043397)
8. H Kubinyi 1996 Evolutionary variable selection in regression and PLS analyses J Chemometr 10 119 133 10.1002/(SICI)1099-128X(199603)10:2<119::AID- CEM409>3.0.CO;2-4 10.1002/(SICI)1099-128X(199603)10:2<119::AID- CEM409>3.0.CO;2-4 1:CAS:528:DyaK28XhslWntr0%3D
9. K Kubo Y Kohar Y Yoshimura Y Shibouta Y Furukawa 1993 Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of potential prodrugs of benzimidazole-7-carboxylic acids J Med Chem 36 2343 2349 10.1021/jm00068a011 10.1021/jm00068a011 1:CAS:528:DyaK3sXlvVSksrs%3D 8360879 (Pubitemid 23262466)
10. A Kurup R Grag DJ Carini C Hansch 2001 Comparative QSAR: angiotensin II antagonists Chem Rev 101 2727 2750 10.1021/cr000025g 10.1021/cr000025g 1:CAS:528:DC%2BD3MXmtF2murw%3D 11749394 (Pubitemid 35377806)
11. F Lindgren P Geladi S Rannar S Wold 1994 Interactive variable selection (IVS) for PLS J Chemometr 8 349 363 10.1002/cem.1180080505 10.1002/cem. 1180080505
12. P Meredith 2004 Modern strategies in hypertension management Eur Heart J Supplements 6 Suppl H H23 H29 10.1093/eurheartj/6.suppl-h.h23
13. A Mimran J Ribstein 1999 Angiotensin receptor blockers: pharmacology and clinical significance J Am Soc Nephrol 10 Suppl 12 S273 S277 1:CAS:528:DyaK1MXisVahtbs%3D 10201882
14. P Morsing G Vauquelin 2001 How can the differences among AT1-receptor antagonists be explained? Cell Biochem Biophys 35 89 102 10.1385/CBB:35:1:89 10.1385/CBB:35:1:89 1:CAS:528:DC%2BD3MXntFSqsLs%3D 11898857 (Pubitemid 33612631)
15. T Tuccinardi V Calderone S Rapposelli A Martinelli 2006 Proposal of a new binding orientation for non-peptide AT1 antagonists J Med Chem 49 4305 4316 10.1021/jm060338p 10.1021/jm060338p 1:CAS:528:DC%2BD28XmtVSjtbo%3D 16821790 (Pubitemid 44036674)
16. MB Vallotton 1987 The renin-angiotensin system Trends Pharmacol Sci 8 69 74 10.1016/0165-6147(87)90013-7 10.1016/0165-6147(87)90013-7 1:CAS:528:DyaL2sXktlehs7g%3D
17. SA Wildman GM Crippen 1999 Prediction of physicochemical parameters by atomic contributions J Chem Inf Comput Sci 39 868 873 10.1021/ci990307l 1:CAS:528:DyaK1MXlt1WjtbY%3D
18. R Willenheimer B Dahlof E Rydberg L Erhardt 1999 AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions Eur Heart J 20 997 1008 10.1053/euhj.1999.1547 10.1053/euhj.1999.1547 1:CAS:528:DyaK1MXksFentbs%3D 10381851 (Pubitemid 29306782)